title: Concentrations of antimony in infants dying from SIDS and infants dying from other causes.
abstract: OBJECTIVE
  Raised concentrations of antimony have been found in infants dying of sudden infant death syndrome (SIDS). The presumed source of this antimony is toxic gases generated from fire retardants that are present in cot mattresses. The aim of this study was to determine the role of antimony in SIDS.
  
  
  METHODS
  Samples of liver, brain, serum, and urine were collected from all patients dying from SIDS and a group of aged matched control infants who had died of other causes.
  
  
  METHODS
  Nationwide study in Ireland.
  
  
  METHODS
  52 infants dying from SIDS and 19 control infants aged > 7 days and < 1 year.
  
  
  RESULTS
  The median concentration of antimony in the liver and brain of infants dying of SIDS was < 1 ng/g, with no difference detected between the infants dying from SIDS and the control infants. The range of antimony in the serum of infants dying of SIDS was 0.09-0.71 microg/litre (median, 0.26). Although no difference was found between infants dying from SIDS and control infants, SIDS infants were found to have higher concentrations when compared with healthy infants in the 1st year of life, probably as a result of release of antimony into serum after death. Urine antimony concentrations in infants dying from SIDS were < 3.91 ng/mg (corrected for creatinine) and similar to values found both in control infants and healthy infants.
  
  
  CONCLUSIONS
  There is no evidence to support a causal role for antimony in SIDS.
authors.affiliation: Department of Paediatrics, University College Dublin, The Children's Hospital, Temple Street, Dublin 1, Republic of Ireland.
authors.forename: A
authors.initials: A
authors.lastname: Cullen
authors.forename: B
authors.initials: B
authors.lastname: Kiberd
authors.forename: D
authors.initials: D
authors.lastname: Devaney
authors.forename: J
authors.initials: J
authors.lastname: Gillan
authors.forename: P
authors.initials: P
authors.lastname: Kelehan
authors.forename: T G
authors.initials: TG
authors.lastname: Matthews
authors.forename: P
authors.initials: P
authors.lastname: Mayne
authors.forename: N
authors.initials: N
authors.lastname: Murphy
authors.forename: M
authors.initials: M
authors.lastname: O'Regan
authors.forename: W
authors.initials: W
authors.lastname: Shannon
authors.forename: L
authors.initials: L
authors.lastname: Thornton
mesh_terms: D000965:Antimony / Q000009:adverse effects* / Q000032:analysis; D001923:Brain Chemistry; D016022:Case-Control Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008099:Liver / Q000737:chemistry; D013398:Sudden Infant Death / Q000209:etiology*
chemical_list: D000965:Antimony